Evaluation of the Response to Chemotherapy in Advanced Gastric Cancer by Contrast-Enhanced Harmonic EUS

被引:8
作者
Matsui, Shigenaga [1 ]
Kudo, Masatoshi [1 ]
Kitano, Masayuki [1 ]
Asakuma, Yutaka [1 ]
机构
[1] Kinki Univ, Fac Med, Dept Gastroenterol & Hepatol, Osakasayama 5898511, Japan
关键词
Advanced gastric cancer; chemotherapy; contrast-enhanced harmonic endoscopic ultrasonography; tumor vascularity; SOLID TUMORS; METASTASIS; VASCULARITY; CARCINOMA;
D O I
10.5754/hge15091
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background/Aims: In advanced gastric cancers, a significant correlation exists between the response to chemotherapy in primary gastric cancers and patient prognosis. Therefore, accurate evaluation of the response to chemotherapy in primary gastric cancers is important. We examined the response to chemotherapy in primary gastric cancers by contrast enhanced harmonic endoscopic ultrasonography (CEH-EUS). Methodology: Thirty-five patients with advanced gastric cancer underwent CEH-EUS. Among these patients, 19 patients with stage IV advanced gastric cancer who received chemotherapy and CEH-EUS more than twice were enrolled, and evaluated the response to chemotherapy in primary gastric cancers by CEH-EUS and endoscopy. Results: In PRs evaluated by endoscopic findings, echo intensity ratio (EIR) was decreased, and in PDs EIR was increased significantly by CEH-EUS. Five cases had difficulty in evaluating the response of primary gastric cancers to chemotherapy by endoscopy, while evaluation was possible in those 5 cases by CEH-EUS. Conclusions: CEH-EUS is a new method to evaluate responses to chemotherapy in primary gastric cancers not only by a change in size but also in tumor vascularity. Correct evaluation of primary gastric cancers by CEH-EUS help predicting prognosis of patients.
引用
收藏
页码:595 / 598
页数:4
相关论文
共 13 条
[1]  
[Anonymous], 1995, JAP CLASS GASTR CARC
[2]  
Araya M, 1997, J SURG ONCOL, V65, P232, DOI 10.1002/(SICI)1096-9098(199708)65:4<232::AID-JSO2>3.0.CO
[3]  
2-6
[4]   New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1) [J].
Eisenhauer, E. A. ;
Therasse, P. ;
Bogaerts, J. ;
Schwartz, L. H. ;
Sargent, D. ;
Ford, R. ;
Dancey, J. ;
Arbuck, S. ;
Gwyther, S. ;
Mooney, M. ;
Rubinstein, L. ;
Shankar, L. ;
Dodd, L. ;
Kaplan, R. ;
Lacombe, D. ;
Verweij, J. .
EUROPEAN JOURNAL OF CANCER, 2009, 45 (02) :228-247
[5]   Advantages of Japanese response criteria for estimating the survival of patients with primary gastric cancer [J].
Wasaburo Koizumi ;
Minoru Kurihara ;
Satoshi Tanabe ;
Ichiei Kondo ;
Izumi Yamazaki ;
Miwa Nonaka ;
Yoshiki Shimamura ;
Katsunori Saigenji .
Gastric Cancer, 1999, 2 (1) :14-19
[6]   RELATION OF NEOVASCULARIZATION TO METASTASIS OF NON-SMALL-CELL LUNG-CANCER [J].
MACCHIARINI, P ;
FONTANINI, G ;
HARDIN, MJ ;
SQUARTINI, F ;
ANGELETTI, CA .
LANCET, 1992, 340 (8812) :145-146
[7]  
Nathalie L, 2006, AJR, V187, P1267
[8]   Response of the primary lesion in gastric cancer to chemotherapeutic trials [J].
Ohtsu A. ;
Boku N. ;
Yoshida S. ;
Miyata Y. ;
Shirao K. ;
Shimada Y. ;
Kurihara M. .
International Journal of Clinical Oncology, 1998, 3 (1) :3-6
[9]   Preoperative assessment of gastric cancer vascularity by flash echo imaging [J].
Okanobu, H ;
Hata, J ;
Haruma, K ;
Matsumura, S ;
Yoshida, S ;
Kitadai, Y ;
Tanaka, S ;
Chayama, K .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2002, 37 (05) :608-612
[10]   Dynamic contrast-enhanced magnetic resonance imaging for assessing tumor vascularity and vascular effects of targeted therapies in renal cell carcinoma [J].
Rosen, Mark A. ;
Schnall, Mitchell D. .
CLINICAL CANCER RESEARCH, 2007, 13 (02) :770S-776S